Who
Michael Mendelsohn
Director
Company insider
Files Form 4 as: Director, Foghorn Therapeutics; Director, Cyclerion Therapeutics; Director, Regado Biosciences.
In numbers
- Trades disclosed
- 14
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 3
- Companies where not an officer
- 3
- First trade
- 1 Jan 2014
- Last trade
- 24 Jun 2026
- Last filed
- 25 Jun 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 24 Jun 2026filed 25 Jun 2026 | FHTX Foghorn Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | $114K28,000 at $4.08 | filing |
| 24 Jun 2026filed 25 Jun 2026 | FHTX Foghorn Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | $114K28,000 at $4.08 | filing |
| 17 Jun 2025filed 17 Jun 2025 | FHTX Foghorn Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | $120K25,000 at $4.79 | filing |
| 26 Jun 2024filed 28 Jun 2024 | FHTX Foghorn Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | $88K16,000 at $5.52 | filing |
| 21 Jun 2023filed 22 Jun 2023 | FHTX Foghorn Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —16,000 at $0.00 | filing |
| 21 Jun 2022filed 22 Jun 2022 | FHTX Foghorn Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —16,000 at $0.00 | filing |
| 14 Jun 2022filed 16 Jun 2022 | Cyclerion Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 13 Jul 2021filed 14 Jul 2021 | FHTX Foghorn Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —12,530 at $0.00 | filing |
| 24 Jun 2021filed 28 Jun 2021 | Cyclerion Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 16 Jun 2020filed 18 Jun 2020 | Cyclerion Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 1 Jun 2019filed 4 Jun 2019 | Cyclerion Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 1 Apr 2019filed 3 Apr 2019 | Cyclerion TherapeuticsBiotechnology | SEC FORM 4 Code A | —2,421 at $0.00 | filing |
| 1 Jan 2015filed 5 Jan 2015 | Regado Biosciencesoption or derivative | SEC FORM 4 Code A | —159,261 at $0.00 | filing |
| 1 Jan 2014filed 3 Jan 2014 | Regado Biosciencesoption or derivative | SEC FORM 4 Code A | —4,820 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.